InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Pharma repurposing: Old drugs, new tricks

James Nurton, London


The development of new uses for existing drugs raises complex questions about patent law, regulation, economics and health policy. James Nurton reports from a recent conference hosted by UCL and Georgetown Law School

The story of thalidomide has three chapters. The first chapter ended in tragedy. The drug was developed by German company Grünenthal in the 1950s to treat morning sickness in pregnant women. The results were devastating: 12,000 children were born with...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

nullnullnull

null

May / June 2019

From trademarks to trade secrets: in-house tips on brand protection in China

Despite the well-known struggles in protecting trademarks and trade secrets in China, there are some tried-and-tested strategies to employ, as Karry Lai and Ellie Mertens hear from in-house counsel at a range of domestic and international companies



Most read articles

Supplements